The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients

• Published in: Clinical and experimental dermatology Vol. 44; no. 3; pp. 265 - 269
• Main Authors: Puza, C. J., Myers, S. A., Cardones, A. R., Beasley, G. M., Mosca, P. J.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.04.2019
• Subjects: Adult; Aged; Carcinoma, Squamous Cell - epidemiology; Carcinoma, Squamous Cell - etiology; Demography; Female; Graft rejection; Graft Rejection - complications; Graft Rejection - epidemiology; Health risk assessment; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Patients; Population Surveillance; Renal cell carcinoma; Skin cancer; Skin Neoplasms - epidemiology; Skin Neoplasms - etiology; Squamous cell carcinoma; Transplants & implants
• ISSN: 0307-6938; 1365-2230
• DOI: 10.1111/ced.13699

Summary Background The incidence of cutaneous squamous cell carcinoma (cSCC) is markedly increased in renal transplant recipients compared with that of the nontransplant population. Aim To investigate whether there is a relationship between transplant rejection and cSCC. Methods The Duke Enterprise Data Unified Content Explorer historical database was used to identify patients who had undergone a renal transplant at Duke University Hospital during a 20‐year period. Data on patient demographics, transplant dates, first rejection episodes, first cSCC development, medication, laboratory results and survival were recorded. Results In total, 1684 patients were identified, of whom 126 (7.5%) experienced an episode of rejection and 46 (4.0%) developed a cSCC after transplant. The incidence of cSCC was significantly greater in the rejection group, with 8.7% of patients developing cSCC compared with 2.2% in the no‐rejection group (P < 0.001). Median lag time to cSCC was shorter in the rejection group (2.5 years; age 0.4–9.0 years) than the no‐rejection group (4.2 years; range 1.3–20.4 years) (P < 0.03). Conclusions Transplant rejection is associated with both a higher incidence and an accelerated time course for development of cSCC following renal transplantation. Close dermatological surveillance should be considered following an episode of rejection in this patient population.